This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsOld MAV Wind-Down (1QQ) 주식 개요Old MAV Wind-Down Ltd. operates as a personal care company worldwide. 자세히 보기1QQ 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적0/6재무 건전성2/6배당0/6강점공정 가치 추정치보다 낮은 97.9% 에서 거래위험 분석지난 5년간 매년 수익이 67.8% 감소했습니다.의미 있는 시가총액이 없습니다(€1M)마이너스 주주 지분지난 3개월 동안 주가 변동성이 German 시장과 비교했을 때 매우 높았습니다.모든 위험 점검 보기1QQ Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.01399.4% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-162m120m2016201920222025202620282031Revenue US$86.4mEarnings US$8.4mAdvancedSet Fair ValueView all narrativesOld MAV Wind-Down Ltd. 경쟁사NosiumSymbol: NGM:NOSIUM BMarket cap: SEK 9.9mMendell HeliumSymbol: OFEX:MDHMarket cap: UK£14.3mUnjha FormulationsSymbol: BSE:531762Market cap: ₹86.6mRolandos EnterprisesSymbol: CSE:ROLMarket cap: €325.0k가격 이력 및 성과Old MAV Wind-Down 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가US$0.01352주 최고가US$0.5852주 최저가US$0.0095베타1.821개월 변동0%3개월 변동-39.53%1년 변동-91.22%3년 변동-99.58%5년 변동-99.79%IPO 이후 변동-99.84%최근 뉴스 및 업데이트공시 • Oct 02MAV Beauty Brands Inc. acquired Sky Organics, LLC.MAV Beauty Brands Inc. acquired Sky Organics, LLC on October 1, 2024. The combined entity will operate under the MAV Beauty umbrella, maintaining headquarters in Toronto, Canada. MAV Beauty Brands Inc. completed the acquisition of Sky Organics, LLC on October 1, 2024.공시 • Nov 16Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc.Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc. on November 14, 2023. MAV Beauty Brands has commenced voluntary proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”) in the Ontario Superior Court of Justice (Commercial List) (the “Court”). Nexus has agreed to acquire substantially all of the assets of the Company and its subsidiaries (the “Transaction”) for a purchase price significantly less than the current principal amount of the outstanding debt ($121.7 million). During the CCAA proceedings, it is expected that MAV Beauty Brands’ operations will continue uninterrupted in the ordinary course of business. In connection with the CCAA proceedings, the Court approved the appointment of Alvarez & Marsal Canada Inc. as monitor of the Company and its subsidiaries (the “Monitor”). Management will remain responsible for the day-to-day operations of the Company and, during the CCAA proceedings, the board of directors of the Company will remain in place, with the Company under the general oversight of the Monitor. It is anticipated that the trading of the Company’s common shares on the Toronto Stock Exchange (the “TSX”) will be halted and the TSX will place the Company under delisting review. A sale approval hearing is currently expected to take place on November 24, 2023 with the anticipated closing of the transaction to occur by the end of 2023, subject to the satisfaction or waiver of customary closing conditions and court approval.공시 • Oct 01MAV Beauty Brands Inc. Announces Board ChangesMAV Beauty Brands Inc. announced that Scott Beattie has joined the Company's Board of Directors (the "Board") as an independent director, effective immediately. Mr. Beattie most recently served as non-executive Vice Chairman of the board of directors of Revlon Inc., and among several other board and executive experiences, previously served as Chairman and Chief Executive Officer of Elizabeth Arden, a global prestige beauty products company. Following Mr. Beattie's appointment, Jeffrey Barber and Kathy Mayor resigned from the Board.Reported Earnings • Aug 10Second quarter 2023 earnings released: US$0.06 loss per share (vs US$0.007 profit in 2Q 2022)Second quarter 2023 results: US$0.06 loss per share (down from US$0.007 profit in 2Q 2022). Revenue: US$20.7m (down 19% from 2Q 2022). Net loss: US$2.22m (down US$2.48m from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 21 percentage points per year, which is a significant difference in performance.공시 • Aug 09MAV Beauty Brands Inc. to Report Q2, 2023 Results on Aug 09, 2023MAV Beauty Brands Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 09, 2023Buying Opportunity • Jul 21Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 44%. The fair value is estimated to be €0.086, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making.더 많은 업데이트 보기Recent updates공시 • Oct 02MAV Beauty Brands Inc. acquired Sky Organics, LLC.MAV Beauty Brands Inc. acquired Sky Organics, LLC on October 1, 2024. The combined entity will operate under the MAV Beauty umbrella, maintaining headquarters in Toronto, Canada. MAV Beauty Brands Inc. completed the acquisition of Sky Organics, LLC on October 1, 2024.공시 • Nov 16Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc.Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc. on November 14, 2023. MAV Beauty Brands has commenced voluntary proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”) in the Ontario Superior Court of Justice (Commercial List) (the “Court”). Nexus has agreed to acquire substantially all of the assets of the Company and its subsidiaries (the “Transaction”) for a purchase price significantly less than the current principal amount of the outstanding debt ($121.7 million). During the CCAA proceedings, it is expected that MAV Beauty Brands’ operations will continue uninterrupted in the ordinary course of business. In connection with the CCAA proceedings, the Court approved the appointment of Alvarez & Marsal Canada Inc. as monitor of the Company and its subsidiaries (the “Monitor”). Management will remain responsible for the day-to-day operations of the Company and, during the CCAA proceedings, the board of directors of the Company will remain in place, with the Company under the general oversight of the Monitor. It is anticipated that the trading of the Company’s common shares on the Toronto Stock Exchange (the “TSX”) will be halted and the TSX will place the Company under delisting review. A sale approval hearing is currently expected to take place on November 24, 2023 with the anticipated closing of the transaction to occur by the end of 2023, subject to the satisfaction or waiver of customary closing conditions and court approval.공시 • Oct 01MAV Beauty Brands Inc. Announces Board ChangesMAV Beauty Brands Inc. announced that Scott Beattie has joined the Company's Board of Directors (the "Board") as an independent director, effective immediately. Mr. Beattie most recently served as non-executive Vice Chairman of the board of directors of Revlon Inc., and among several other board and executive experiences, previously served as Chairman and Chief Executive Officer of Elizabeth Arden, a global prestige beauty products company. Following Mr. Beattie's appointment, Jeffrey Barber and Kathy Mayor resigned from the Board.Reported Earnings • Aug 10Second quarter 2023 earnings released: US$0.06 loss per share (vs US$0.007 profit in 2Q 2022)Second quarter 2023 results: US$0.06 loss per share (down from US$0.007 profit in 2Q 2022). Revenue: US$20.7m (down 19% from 2Q 2022). Net loss: US$2.22m (down US$2.48m from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 21 percentage points per year, which is a significant difference in performance.공시 • Aug 09MAV Beauty Brands Inc. to Report Q2, 2023 Results on Aug 09, 2023MAV Beauty Brands Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 09, 2023Buying Opportunity • Jul 21Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 44%. The fair value is estimated to be €0.086, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making.공시 • May 25MAV Beauty Brands Provides Board UpdateMAV Beauty Brands Inc. announced that Marc Anthony Venere has resigned from the Board of Directors, effective May 23, 2023. Mr. Venere is considering whether or not to participate in the Company's strategic review process and resigned from the Board of Directors to avoid any actual or perceived conflict in the event of his potential future participation in the strategic review process. There can be no assurances or guarantees that Mr. Venere will participate in the strategic review process or, if Mr. Venere does participate, the timing or terms of such participation. Given Mr. Venere's resignation, there are currently four director nominees proposed for election to the Board of Directors at the annual general meeting of shareholders of the Company to be held on June 13, 2023 (the "Meeting"), as further described in the Company's management information circular dated May 3, 2023 (the "Circular"). These remaining director nominees are Chris Elshaw, Jeffrey Barber, Stephen Smith and Kathy Mayor. The Company will not be replacing Mr. Venere with a new director nominee for election to the Board of Directors at the Meeting.Reported Earnings • May 12First quarter 2023 earnings released: US$0.10 loss per share (vs US$0.017 loss in 1Q 2022)First quarter 2023 results: US$0.10 loss per share (further deteriorated from US$0.017 loss in 1Q 2022). Revenue: US$19.3m (down 8.9% from 1Q 2022). Net loss: US$3.87m (loss widened US$3.24m from 1Q 2022). Revenue is forecast to stay flat during the next 2 years compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.Buying Opportunity • Apr 03Now 62% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be €0.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 8.1% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 9.6% in a year. Earnings is forecast to grow by 94% in the next year.Reported Earnings • Apr 02Full year 2022 earnings released: US$4.24 loss per share (vs US$2.66 loss in FY 2021)Full year 2022 results: US$4.24 loss per share (further deteriorated from US$2.66 loss in FY 2021). Revenue: US$90.7m (down 15% from FY 2021). Net loss: US$155.8m (loss widened 60% from FY 2021). Revenue is forecast to grow 3.9% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.Buying Opportunity • Mar 17Now 27% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be €0.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 0.6% in a year. Earnings is forecast to grow by 68% in the next year.Buying Opportunity • Feb 28Now 26% undervaluedOver the last 90 days, the stock is up 46%. The fair value is estimated to be €0.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 0.6% in a year. Earnings is forecast to grow by 68% in the next year.Board Change • Dec 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Director Kathy Mayor was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Nov 18Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Director Kathy Mayor was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 04Third quarter 2022 earnings released: US$2.54 loss per share (vs US$2.81 loss in 3Q 2021)Third quarter 2022 results: US$2.54 loss per share (improved from US$2.81 loss in 3Q 2021). Revenue: US$22.0m (down 11% from 3Q 2021). Net loss: US$93.5m (loss narrowed 9.3% from 3Q 2021). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance.Board Change • Oct 04Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 12Second quarter 2022 earnings released: EPS: US$0.007 (vs US$0.11 in 2Q 2021)Second quarter 2022 results: EPS: US$0.007 (down from US$0.11 in 2Q 2021). Revenue: US$25.4m (down 13% from 2Q 2021). Net income: US$264.0k (down 94% from 2Q 2021). Profit margin: 1.0% (down from 14% in 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 8.0% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.Board Change • Jul 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • May 13First quarter 2022 earnings released: US$0.017 loss per share (vs US$0.043 profit in 1Q 2021)First quarter 2022 results: US$0.017 loss per share (down from US$0.043 profit in 1Q 2021). Revenue: US$21.1m (down 26% from 1Q 2021). Net loss: US$632.0k (down 140% from profit in 1Q 2021). Over the next year, revenue is forecast to grow 8.1%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Nov 19CEO & President recently bought €481k worth of stockOn the 16th of November, Serge Jureidini bought around 500k shares on-market at roughly €0.96 per share. This was the largest purchase by an insider in the last 3 months. This was Serge's only on-market trade for the last 12 months.Reported Earnings • Nov 09Third quarter 2021 earnings released: US$2.81 loss per share (vs US$0.097 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: US$24.7m (down 22% from 3Q 2020). Net loss: US$103.1m (down US$106.7m from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has fallen by 44% per year, which means it is performing significantly worse than earnings.Board Change • Sep 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Sep 02Investor sentiment deteriorated over the past weekAfter last week's 38% share price decline to €1.60, the stock trades at a trailing P/E ratio of 7.3x. Average forward P/E is 32x in the Personal Products industry in Europe. Total loss to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €2.18 per share.Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS US$0.11 (vs US$0.044 in 2Q 2020)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: US$29.1m (down 1.8% from 2Q 2020). Net income: US$4.08m (up 154% from 2Q 2020). Profit margin: 14% (up from 5.4% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Jul 15Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to US$2.62, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 33x in the Personal Products industry in Europe. Total returns to shareholders of 88% over the past year.Reported Earnings • May 11First quarter 2021 earnings released: EPS US$0.043 (vs US$0.034 in 1Q 2020)The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: US$28.6m (down 8.7% from 1Q 2020). Net income: US$1.58m (up 28% from 1Q 2020). Profit margin: 5.5% (up from 3.9% in 1Q 2020).Executive Departure • May 11Chief Financial Officer has left the companyOn the 10th of May, Judy Adam's tenure as Chief Financial Officer ended after 2.1 years in the role. We don't have any record of a personal shareholding under Judy's name. Judy is the only executive to leave the company over the last 12 months.Reported Earnings • Apr 02Full year 2020 earnings released: EPS US$0.18 (vs US$0.11 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$116.5m (up 7.4% from FY 2019). Net income: US$6.51m (up 60% from FY 2019). Profit margin: 5.6% (up from 3.8% in FY 2019).Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to US$3.74, the stock is trading at a trailing P/E ratio of 33.1x, down from the previous P/E ratio of 39.8x. This compares to an average P/E of 21x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 28%.Is New 90 Day High Low • Feb 10New 90-day high: €4.60The company is up 42% from its price of €3.24 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €10.11 per share.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 15% share price gain to US$3.94, the stock is trading at a trailing P/E ratio of 35.2x, up from the previous P/E ratio of 30.5x. This compares to an average P/E of 23x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 27%.Valuation Update With 7 Day Price Move • Jan 15Investor sentiment improved over the past weekAfter last week's 18% share price gain to US$3.70, the stock is trading at a trailing P/E ratio of 32.4x, up from the previous P/E ratio of 27.5x. This compares to an average P/E of 23x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 8.2%.Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to US$3.50, the stock is trading at a trailing P/E ratio of 31x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 22x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 7.4%.Is New 90 Day High Low • Jan 13New 90-day high: €3.48The company is up 53% from its price of €2.28 on 15 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.51 per share.Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS US$0.097The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$31.7m (up 12% from 3Q 2019). Net income: US$3.56m (up 21% from 3Q 2019). Profit margin: 11% (up from 10% in 3Q 2019). The increase in margin was driven by higher revenue.Analyst Estimate Surprise Post Earnings • Nov 14Revenue beats expectationsRevenue exceeded analyst estimates by 4.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 1.5% growth forecast for the Personal Products industry in Germany.Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 21% share price gain to US$2.96, the stock is trading at a trailing P/E ratio of 29.1x, up from the previous P/E ratio of 24x. This compares to an average P/E of 20x in the Personal Products industry in Europe. Total return to shareholders over the past year is a loss of 12%.Is New 90 Day High Low • Nov 07New 90-day high: €2.54The company is up 69% from its price of €1.50 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.61 per share.Is New 90 Day High Low • Oct 11New 90-day high: €2.42The company is up 73% from its price of €1.40 on 13 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.83 per share.주주 수익률1QQDE Personal ProductsDE 시장7D0%0.9%3.2%1Y-91.2%-11.7%2.5%전체 주주 수익률 보기수익률 대 산업: 1QQ은 지난 1년 동안 -11.7%의 수익을 기록한 German Personal Products 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 1QQ은 지난 1년 동안 2.5%를 기록한 German 시장보다 저조한 성과를 냈습니다.주가 변동성Is 1QQ's price volatile compared to industry and market?1QQ volatility1QQ Average Weekly Movement87.5%Personal Products Industry Average Movement5.2%Market Average Movement6.1%10% most volatile stocks in DE Market13.3%10% least volatile stocks in DE Market2.7%안정적인 주가: 1QQ의 주가는 지난 3개월 동안 German 시장보다 변동성이 컸습니다.시간에 따른 변동성: 1QQ의 주간 변동성은 지난 1년간 62%에서 88%로 증가했습니다.회사 소개설립직원 수CEO웹사이트199573Serge Jureidiniinvestors.mavbeautybrands.com/ir-home/default.aspx더 보기Old MAV Wind-Down Ltd. 기초 지표 요약Old MAV Wind-Down의 순이익과 매출은 시가총액과 어떻게 비교됩니까?1QQ 기초 통계시가총액€1.34m순이익 (TTM)-€161.56m매출 (TTM)€84.11m0.0x주가매출비율(P/S)0.0x주가수익비율(P/E)1QQ는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표1QQ 손익계산서 (TTM)매출US$84.11m매출원가US$48.54m총이익US$35.57m기타 비용US$197.13m순이익-US$161.56m최근 보고된 실적Jun 30, 2023다음 실적 발표일해당 없음주당순이익(EPS)-4.37총이익률42.29%순이익률-192.08%부채/자본 비율-616.0%1QQ의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/01/01 12:14종가2023/11/14 00:00수익2023/06/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Old MAV Wind-Down Ltd.는 8명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Nick CorcoranAcumen Capital Finance Partners LimitedShannon CoyneBMO Capital Markets Equity ResearchMatthew LeeCanaccord Genuity5명의 분석가 더 보기
공시 • Oct 02MAV Beauty Brands Inc. acquired Sky Organics, LLC.MAV Beauty Brands Inc. acquired Sky Organics, LLC on October 1, 2024. The combined entity will operate under the MAV Beauty umbrella, maintaining headquarters in Toronto, Canada. MAV Beauty Brands Inc. completed the acquisition of Sky Organics, LLC on October 1, 2024.
공시 • Nov 16Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc.Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc. on November 14, 2023. MAV Beauty Brands has commenced voluntary proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”) in the Ontario Superior Court of Justice (Commercial List) (the “Court”). Nexus has agreed to acquire substantially all of the assets of the Company and its subsidiaries (the “Transaction”) for a purchase price significantly less than the current principal amount of the outstanding debt ($121.7 million). During the CCAA proceedings, it is expected that MAV Beauty Brands’ operations will continue uninterrupted in the ordinary course of business. In connection with the CCAA proceedings, the Court approved the appointment of Alvarez & Marsal Canada Inc. as monitor of the Company and its subsidiaries (the “Monitor”). Management will remain responsible for the day-to-day operations of the Company and, during the CCAA proceedings, the board of directors of the Company will remain in place, with the Company under the general oversight of the Monitor. It is anticipated that the trading of the Company’s common shares on the Toronto Stock Exchange (the “TSX”) will be halted and the TSX will place the Company under delisting review. A sale approval hearing is currently expected to take place on November 24, 2023 with the anticipated closing of the transaction to occur by the end of 2023, subject to the satisfaction or waiver of customary closing conditions and court approval.
공시 • Oct 01MAV Beauty Brands Inc. Announces Board ChangesMAV Beauty Brands Inc. announced that Scott Beattie has joined the Company's Board of Directors (the "Board") as an independent director, effective immediately. Mr. Beattie most recently served as non-executive Vice Chairman of the board of directors of Revlon Inc., and among several other board and executive experiences, previously served as Chairman and Chief Executive Officer of Elizabeth Arden, a global prestige beauty products company. Following Mr. Beattie's appointment, Jeffrey Barber and Kathy Mayor resigned from the Board.
Reported Earnings • Aug 10Second quarter 2023 earnings released: US$0.06 loss per share (vs US$0.007 profit in 2Q 2022)Second quarter 2023 results: US$0.06 loss per share (down from US$0.007 profit in 2Q 2022). Revenue: US$20.7m (down 19% from 2Q 2022). Net loss: US$2.22m (down US$2.48m from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 21 percentage points per year, which is a significant difference in performance.
공시 • Aug 09MAV Beauty Brands Inc. to Report Q2, 2023 Results on Aug 09, 2023MAV Beauty Brands Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 09, 2023
Buying Opportunity • Jul 21Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 44%. The fair value is estimated to be €0.086, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making.
공시 • Oct 02MAV Beauty Brands Inc. acquired Sky Organics, LLC.MAV Beauty Brands Inc. acquired Sky Organics, LLC on October 1, 2024. The combined entity will operate under the MAV Beauty umbrella, maintaining headquarters in Toronto, Canada. MAV Beauty Brands Inc. completed the acquisition of Sky Organics, LLC on October 1, 2024.
공시 • Nov 16Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc.Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc. on November 14, 2023. MAV Beauty Brands has commenced voluntary proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”) in the Ontario Superior Court of Justice (Commercial List) (the “Court”). Nexus has agreed to acquire substantially all of the assets of the Company and its subsidiaries (the “Transaction”) for a purchase price significantly less than the current principal amount of the outstanding debt ($121.7 million). During the CCAA proceedings, it is expected that MAV Beauty Brands’ operations will continue uninterrupted in the ordinary course of business. In connection with the CCAA proceedings, the Court approved the appointment of Alvarez & Marsal Canada Inc. as monitor of the Company and its subsidiaries (the “Monitor”). Management will remain responsible for the day-to-day operations of the Company and, during the CCAA proceedings, the board of directors of the Company will remain in place, with the Company under the general oversight of the Monitor. It is anticipated that the trading of the Company’s common shares on the Toronto Stock Exchange (the “TSX”) will be halted and the TSX will place the Company under delisting review. A sale approval hearing is currently expected to take place on November 24, 2023 with the anticipated closing of the transaction to occur by the end of 2023, subject to the satisfaction or waiver of customary closing conditions and court approval.
공시 • Oct 01MAV Beauty Brands Inc. Announces Board ChangesMAV Beauty Brands Inc. announced that Scott Beattie has joined the Company's Board of Directors (the "Board") as an independent director, effective immediately. Mr. Beattie most recently served as non-executive Vice Chairman of the board of directors of Revlon Inc., and among several other board and executive experiences, previously served as Chairman and Chief Executive Officer of Elizabeth Arden, a global prestige beauty products company. Following Mr. Beattie's appointment, Jeffrey Barber and Kathy Mayor resigned from the Board.
Reported Earnings • Aug 10Second quarter 2023 earnings released: US$0.06 loss per share (vs US$0.007 profit in 2Q 2022)Second quarter 2023 results: US$0.06 loss per share (down from US$0.007 profit in 2Q 2022). Revenue: US$20.7m (down 19% from 2Q 2022). Net loss: US$2.22m (down US$2.48m from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 21 percentage points per year, which is a significant difference in performance.
공시 • Aug 09MAV Beauty Brands Inc. to Report Q2, 2023 Results on Aug 09, 2023MAV Beauty Brands Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 09, 2023
Buying Opportunity • Jul 21Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 44%. The fair value is estimated to be €0.086, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making.
공시 • May 25MAV Beauty Brands Provides Board UpdateMAV Beauty Brands Inc. announced that Marc Anthony Venere has resigned from the Board of Directors, effective May 23, 2023. Mr. Venere is considering whether or not to participate in the Company's strategic review process and resigned from the Board of Directors to avoid any actual or perceived conflict in the event of his potential future participation in the strategic review process. There can be no assurances or guarantees that Mr. Venere will participate in the strategic review process or, if Mr. Venere does participate, the timing or terms of such participation. Given Mr. Venere's resignation, there are currently four director nominees proposed for election to the Board of Directors at the annual general meeting of shareholders of the Company to be held on June 13, 2023 (the "Meeting"), as further described in the Company's management information circular dated May 3, 2023 (the "Circular"). These remaining director nominees are Chris Elshaw, Jeffrey Barber, Stephen Smith and Kathy Mayor. The Company will not be replacing Mr. Venere with a new director nominee for election to the Board of Directors at the Meeting.
Reported Earnings • May 12First quarter 2023 earnings released: US$0.10 loss per share (vs US$0.017 loss in 1Q 2022)First quarter 2023 results: US$0.10 loss per share (further deteriorated from US$0.017 loss in 1Q 2022). Revenue: US$19.3m (down 8.9% from 1Q 2022). Net loss: US$3.87m (loss widened US$3.24m from 1Q 2022). Revenue is forecast to stay flat during the next 2 years compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.
Buying Opportunity • Apr 03Now 62% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be €0.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 8.1% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 9.6% in a year. Earnings is forecast to grow by 94% in the next year.
Reported Earnings • Apr 02Full year 2022 earnings released: US$4.24 loss per share (vs US$2.66 loss in FY 2021)Full year 2022 results: US$4.24 loss per share (further deteriorated from US$2.66 loss in FY 2021). Revenue: US$90.7m (down 15% from FY 2021). Net loss: US$155.8m (loss widened 60% from FY 2021). Revenue is forecast to grow 3.9% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
Buying Opportunity • Mar 17Now 27% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be €0.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 0.6% in a year. Earnings is forecast to grow by 68% in the next year.
Buying Opportunity • Feb 28Now 26% undervaluedOver the last 90 days, the stock is up 46%. The fair value is estimated to be €0.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 0.6% in a year. Earnings is forecast to grow by 68% in the next year.
Board Change • Dec 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Director Kathy Mayor was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Nov 18Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Director Kathy Mayor was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 04Third quarter 2022 earnings released: US$2.54 loss per share (vs US$2.81 loss in 3Q 2021)Third quarter 2022 results: US$2.54 loss per share (improved from US$2.81 loss in 3Q 2021). Revenue: US$22.0m (down 11% from 3Q 2021). Net loss: US$93.5m (loss narrowed 9.3% from 3Q 2021). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance.
Board Change • Oct 04Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 12Second quarter 2022 earnings released: EPS: US$0.007 (vs US$0.11 in 2Q 2021)Second quarter 2022 results: EPS: US$0.007 (down from US$0.11 in 2Q 2021). Revenue: US$25.4m (down 13% from 2Q 2021). Net income: US$264.0k (down 94% from 2Q 2021). Profit margin: 1.0% (down from 14% in 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 8.0% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
Board Change • Jul 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 13First quarter 2022 earnings released: US$0.017 loss per share (vs US$0.043 profit in 1Q 2021)First quarter 2022 results: US$0.017 loss per share (down from US$0.043 profit in 1Q 2021). Revenue: US$21.1m (down 26% from 1Q 2021). Net loss: US$632.0k (down 140% from profit in 1Q 2021). Over the next year, revenue is forecast to grow 8.1%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Nov 19CEO & President recently bought €481k worth of stockOn the 16th of November, Serge Jureidini bought around 500k shares on-market at roughly €0.96 per share. This was the largest purchase by an insider in the last 3 months. This was Serge's only on-market trade for the last 12 months.
Reported Earnings • Nov 09Third quarter 2021 earnings released: US$2.81 loss per share (vs US$0.097 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: US$24.7m (down 22% from 3Q 2020). Net loss: US$103.1m (down US$106.7m from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has fallen by 44% per year, which means it is performing significantly worse than earnings.
Board Change • Sep 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment deteriorated over the past weekAfter last week's 38% share price decline to €1.60, the stock trades at a trailing P/E ratio of 7.3x. Average forward P/E is 32x in the Personal Products industry in Europe. Total loss to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €2.18 per share.
Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS US$0.11 (vs US$0.044 in 2Q 2020)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: US$29.1m (down 1.8% from 2Q 2020). Net income: US$4.08m (up 154% from 2Q 2020). Profit margin: 14% (up from 5.4% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Jul 15Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to US$2.62, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 33x in the Personal Products industry in Europe. Total returns to shareholders of 88% over the past year.
Reported Earnings • May 11First quarter 2021 earnings released: EPS US$0.043 (vs US$0.034 in 1Q 2020)The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: US$28.6m (down 8.7% from 1Q 2020). Net income: US$1.58m (up 28% from 1Q 2020). Profit margin: 5.5% (up from 3.9% in 1Q 2020).
Executive Departure • May 11Chief Financial Officer has left the companyOn the 10th of May, Judy Adam's tenure as Chief Financial Officer ended after 2.1 years in the role. We don't have any record of a personal shareholding under Judy's name. Judy is the only executive to leave the company over the last 12 months.
Reported Earnings • Apr 02Full year 2020 earnings released: EPS US$0.18 (vs US$0.11 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$116.5m (up 7.4% from FY 2019). Net income: US$6.51m (up 60% from FY 2019). Profit margin: 5.6% (up from 3.8% in FY 2019).
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to US$3.74, the stock is trading at a trailing P/E ratio of 33.1x, down from the previous P/E ratio of 39.8x. This compares to an average P/E of 21x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 28%.
Is New 90 Day High Low • Feb 10New 90-day high: €4.60The company is up 42% from its price of €3.24 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €10.11 per share.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 15% share price gain to US$3.94, the stock is trading at a trailing P/E ratio of 35.2x, up from the previous P/E ratio of 30.5x. This compares to an average P/E of 23x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 27%.
Valuation Update With 7 Day Price Move • Jan 15Investor sentiment improved over the past weekAfter last week's 18% share price gain to US$3.70, the stock is trading at a trailing P/E ratio of 32.4x, up from the previous P/E ratio of 27.5x. This compares to an average P/E of 23x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 8.2%.
Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to US$3.50, the stock is trading at a trailing P/E ratio of 31x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 22x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 7.4%.
Is New 90 Day High Low • Jan 13New 90-day high: €3.48The company is up 53% from its price of €2.28 on 15 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.51 per share.
Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS US$0.097The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$31.7m (up 12% from 3Q 2019). Net income: US$3.56m (up 21% from 3Q 2019). Profit margin: 11% (up from 10% in 3Q 2019). The increase in margin was driven by higher revenue.
Analyst Estimate Surprise Post Earnings • Nov 14Revenue beats expectationsRevenue exceeded analyst estimates by 4.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 1.5% growth forecast for the Personal Products industry in Germany.
Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 21% share price gain to US$2.96, the stock is trading at a trailing P/E ratio of 29.1x, up from the previous P/E ratio of 24x. This compares to an average P/E of 20x in the Personal Products industry in Europe. Total return to shareholders over the past year is a loss of 12%.
Is New 90 Day High Low • Nov 07New 90-day high: €2.54The company is up 69% from its price of €1.50 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.61 per share.
Is New 90 Day High Low • Oct 11New 90-day high: €2.42The company is up 73% from its price of €1.40 on 13 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.83 per share.
